ALPCO will promote its new STELLUX® Chemi Active GLP-1 (7-36) amide ELISA and Young Investigators Travel Grant Program at the American Diabetes Association’s 78th Scientific Sessions June 23-25, 2018 in Orlando, FL.
InSphero extends 3D InSight™ Diabetes Discovery Platform to include ALPCO STELLUX® Chemiluminescent ELISA technology for assessment of pancreatic β-cell function.
Download our eBook to learn about the mechanisms behind organ crosstalk in obesity and NAFLD.
Celebrate International Women's Day 2018 by learning about Dorothy Hodgkin's discovery of insulin's 3D structure.
Learn how scientists are exploring the relationship between the gut microbiota and gut-liver crosstalk to better understand metabolic diseases like non-alcoholic fatty liver disease.